NCT01086813View on ClinicalTrials.gov

Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
SafetyTolerabilityPharmacokineticsSedation
Interventions
DRUG

AZD3043

single dose/IV, bolus over 60secs - infusion over 30 mins

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY